Brain metastases are a very common manifestation of cancer that have historically been
approached as a single disease entity given the uniform association with poor clinical …

Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited
understanding of brain metastasis tumor and immune biology, drivers of resistance to …

Objective While postoperative resection cavity radiosurgery (post-SRS) is an accepted
treatment paradigm for brain metastasis (BM) patients who undergo surgical resection, there …

The development of brain metastases occurs in 10–20% of all patients with cancer. Brain
metastases portend poor survival and contribute to increased cancer mortality and morbidity …

Simple Summary In the multi-modal treatment of brain metastasis (BM), the role of systemic
therapy has undergone a recent revolution. Due to the development of multiple agents with …

ABSTRACT Introduction Brain metastasis (BrM) is a key contributor to morbidity and
mortality in breast cancer patients, especially among high-risk epidermal growth factor …

Simple Summary Brain metastases are of increasing concern in the management of cancer
patients. New systemic treatment options like specific targeting agents or immune …

Radiotherapy (RT) is one of the cornerstones in the current treatment paradigm for
glioblastoma (GBM). However, little has changed in the management of GBM since the …

Introduction Glioblastoma is an aggressive cancer with a notoriously poor prognosis. Recent
advances in treatment have increased overall survival, though this may be accompanied by …

Importance Brain metastasis (BM) is the most common malignant intracranial neoplasm in
adults with over 100,000 new cases annually in the United States and outnumbering primary …